Hepatitis C: all 2,356 studies
Page 22 of 24. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.
- A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.CompletedNCT00517439Phase 2
- Factors Associated to Success of Hepatitis C TherapyCompletedNCT00514111
- Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency VirusCompletedNCT00503347Phase 1
- Short Course of Interferon Treatment in Patients With HCV InfectionCompletedNCT00502970Phase 4
- Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study)CompletedNCT00502788Phase 2
- Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4CompletedNCT00502099Phase 4
- Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.CompletedNCT00502086Phase 3
- Chiron Corp HCV E1/E2 VaccineCompletedNCT00500747Phase 1
- Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C VirusStatus unknownNCT00499434
- Reducing Depressive Symptoms During HCV Therapy: A Randomized StudyStatus unknownNCT00495768Not applicable
- Effects of HIV and Hepatitis C Virus on the BrainCompletedNCT00494936
- Mucomyst for Hepatitis CSuspendedNCT00493610Not applicable
- Fluvastatin, Rosuvastatin Added to Pegylated Interferon and RibavirinCompletedNCT00487318Phase 2
- RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of RibavirinStatus unknownNCT00485342Phase 3
- Ribavirin, Its Dosing RegimeCompletedNCT00484328Phase 4
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.CompletedNCT00475072Phase 4
- Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, SwitzerlandCompletedNCT00473993
- Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment RegimensCompletedNCT00470210Phase 4
- Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + SteroidCompletedNCT00469131Phase 3
- Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler IndicesCompletedNCT00466336
- Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation StudyCompletedNCT00466271
- Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver TransplantCompletedNCT00466219Phase 3
- Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and RibavirinTerminatedNCT00456248Phase 4
- TG4040 in Patients With Chronic HCVWithdrawnNCT00449124Phase 1
- Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis CCompletedNCT00446940Phase 2
- Phase I Hepatitis C Vaccine Trial of Virosome-formulated PeptidesCompletedNCT00445419Phase 1
- Oxidative Stress and Fatty Acids in Hepatitis CCompletedNCT00444002
- Fluvastatin Versus Hepatitis C VirusCompletedNCT00441493Not applicable
- Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected AdultsTerminatedNCT00439959Phase 1
- Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) TherapyStatus unknownNCT00437684Phase 3
- Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV TherapyStatus unknownNCT00437476Phase 3
- Characterization of Clonal B Cell Populations in HCV InfectionCompletedNCT00435201
- Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis CCompletedNCT00433108Phase 2
- Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus PioglitazoneCompletedNCT00433069Phase 2
- Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.CompletedNCT00422838
- Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis CCompletedNCT00421434Phase 2/3
- Study of Nitazoxanide in the Treatment of Chronic Hepatitis CCompletedNCT00418639Phase 2
- Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis CCompletedNCT00418054Phase 2
- SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.CompletedNCT00412334Phase 4
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3CompletedNCT00411385Phase 3
- Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha.Status unknownNCT00408304Phase 2
- Overcoming Psychiatric Barriers to the Treatment of Hepatitis CCompletedNCT00407732Not applicable
- Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C VirusCompletedNCT00403533Phase 2
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive PatientsCompletedNCT00402428Phase 3
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ACH-0137171 in Participants With Chronic Hepatitis C InfectionTerminatedNCT00401947Phase 2
- Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance ImagingCompletedNCT00401336Not applicable
- Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis CStatus unknownNCT00399815
- Evaluation of a Multi-disciplinary Approach for the Treatment of Hepatitis C in IDUs (HI-LO Study)CompletedNCT00399672Not applicable
- Study to Evaluate Drug-drug Interaction Between Valopicitabine and RibavirinCompletedNCT00395421Phase 2
- Determining Responses to Two Different Vaccines in HIV and HCV Infected IndividualsCompletedNCT00393276Phase 1
- Study to Reduce Intravenous Exposures (STRIVE)CompletedNCT00391482Phase 2/3
- Phase I Trial of Silymarin for Chronic Liver DiseasesCompletedNCT00389376Phase 1
- A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.CompletedNCT00389298Phase 1/2
- Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.CompletedNCT00383864Phase 4
- Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and RibavirinCompletedNCT00382798Phase 1/2
- Risk Assessment of Long-Haul Truck DriversCompletedNCT00381992
- High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCVCompletedNCT00381953Phase 3
- Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)WithdrawnNCT00381017Phase 3
- A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.CompletedNCT00377182Phase 2
- Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver TransplantationTerminatedNCT00375895Phase 3
- Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCCCompletedNCT00375661Phase 4
- Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard TherapyCompletedNCT00372983Phase 1
- Rosuvastatin for Hepatitis CWithdrawnNCT00371579Not applicable
- Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin ResistanceStatus unknownNCT00370617Phase 4
- Transplant-Related Accelerated Progression of Hepatitis CCompletedNCT00368225
- A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder SubjectsCompletedNCT00367887Phase 2
- Pegintron Induction Therapy in HCV Non-RespondersCompletedNCT00363259Phase 3
- Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis CCompletedNCT00361179
- Hepatitis C in Adults Who Underwent Congenital Heart Surgery Before ScreeningTerminatedNCT00359099
- Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C InfectionCompletedNCT00352235Phase 1/2
- Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol TherapyCompletedNCT00351871Phase 4
- Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 InfectionCompletedNCT00351403Phase 4
- BreathID Multi-center HCV Liver Breath Test StudyTerminatedNCT00350714Phase 2
- Screening for Hepatitis C During Pregnancy at a Toronto Inner City Prenatal ClinicCompletedNCT00348660
- Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis CCompletedNCT00343525Phase 1
- Association Between Hepatitis C Virus Infection and Hematologic and Thyroid CancersCompletedNCT00342641
- The Second Multicenter Hemophilia Cohort StudyCompletedNCT00341705
- Continuing Treatment With Pegasys and CopegusStatus unknownNCT00336518Phase 3
- A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis CStatus unknownNCT00332176Phase 2
- A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV)CompletedNCT00328549Phase 2
- Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood LymphocytesCompletedNCT00324389Phase 2
- Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.CompletedNCT00323804Phase 2/3
- Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis CCompletedNCT00322179
- Trial of Citalopram for the Prevention of DepressionCompletedNCT00317746Phase 3
- NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus CoinfectionCompletedNCT00315432Phase 2
- Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy AdultsCompletedNCT00314054Phase 1
- Chronic Hepatitis C Non-Responder Study With AdoMet and BetaineCompletedNCT00310336Phase 2/3
- 14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological ResponseCompletedNCT00308048Phase 3
- Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis CTerminatedNCT00305383Phase 2
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)CompletedNCT00304551Phase 3
- Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) CirrhosisCompletedNCT00301509Phase 2/3
- Study of XTL6865 in Patients With Chronic Hepatitis C Virus InfectionStatus unknownNCT00300807Phase 1
- Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve SubjectsCompletedNCT00299936Phase 3
- Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination TherapyStatus unknownNCT00299923Phase 3
- Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis CCompletedNCT00298714Phase 4
- Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral MedicationTerminatedNCT00296972Phase 3
- Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant PatientsCompletedNCT00295607Phase 2
- Methacetin Breath Test in HCV Patients With Normal and Near-Normal ALTStatus unknownNCT00294489
- An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 InfectionCompletedNCT00292084Phase 2
- Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing RegimenCompletedNCT00286871Phase 1